StemBioSys Announces European Distribution Agreement with Cellaviva AB of Sweden

SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with

Cellaviva AB to distribute and market StemBioSys products. Cellaviva will be the exclusive

distributor for StemBioSys in Sweden and Denmark. The agreement also grants nonexclusive

rights to Cellaviva for the remainder of Europe.

Initially, the agreement will cover StemBioSys’ cell expansion product BM-HPME®, but

as additional products are added to StemBioSys’ portfolio in the future, these products likely will

also be included in the distribution agreement, according to StemBioSys President & CEO Bob

Hutchens.

“Europe is one of the leading areas in stem cell research and we are delighted to have

the opportunity to gain direct access to this market though our partnership with Cellaviva,”

Hutchens said. “In Sweden and Denmark, Cellaviva has a unique leading position in stem cell

research, and we are very pleased to announce them as our e

< | >